Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
Frequency of Blood-tissue Parasitic Infections in Patients with Multiple Sclerosis, as Compared to their Family Members.
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.
Acute transverse myelitis in a child with lyme disease and a review of literature.
Structural and construct validity of the Leeds Multiple Sclerosis Quality of Life scale.
Childhood Guillain-Barré syndrome subtypes in northern India.
Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis.
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.
Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?
Social Cognitive Predictors of Physical Activity in Relapsing-Remitting Multiple Sclerosis.
Inhibitors of myelination: ECM changes, CSPGs and PTPs.
The reliability and validity study of the Kinesthetic and Visual Imagery Questionnaire in individuals with Multiple Sclerosis.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Uhthoff's phenomenon as the first manifestation of multiple sclerosis in an adult male.
Disease-modifying agents in multiple sclerosis.
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
[Prognostic factors of multiple sclerosis in children and adolescents after the first demyelinating event.]
Long term cardiac safety and tolerability of Fingolimod in Multiple Sclerosis: A post-marketing study.
Erratum to: Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV.
Research Findings on Overactive Bladder.
Reactivation of herpesvirus under fingolimod: A case of severe herpes simplex encephalitis.
Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics.
Pages
« first
‹ previous
…
566
567
568
569
570
571
572
573
574
…
next ›
last »